Who owns Revolution Medicines (RVMD)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Revolution Medicines (RVMD) in their latest 13F filing, with $5.2B between them. Andrew Spokes gives it the most weight: 14.4% of the reported portfolio. In their latest reported quarter, Julian and Felix Baker, Stanley Druckenmiller and Louis Bacon added; Andrew Spokes and Brandon Haley reduced.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Andrew Spokes, $2.8B
- Largest weight
- Andrew Spokes, 14.4%of their portfolio
- Combined value
- $5.2B
- Bought last quarter
- 3
- Sold last quarter
- 2
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Andrew SpokesFarallon Capital Management | 14.4% | $2.8B | 13.42M | ▼ Reduced 1.0% | −131.44K | Q3 2026 |
| 2 | Julian and Felix BakerBaker Bros. Advisors | 10.7% | $2.1B | 11.44M | ▲ Added 20% | +1.89M | Q2 2026 |
| 3 | Stanley DruckenmillerDuquesne Family Office | 1.72% | $74.8M | 399.59K | ▲ Added 27% | +83.73K | Q2 2026 |
| 4 | Brandon HaleyHolocene Advisors | 0.58% | $254.6M | 1.36M | ▼ Reduced 45% | −1.11M | Q2 2026 |
| 5 | Louis BaconMoore Capital Management | 0.49% | $17.5M | 85.18K | ▲ Added 4.3% | +3.48K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 13.5M | $2.8B | 1 | 1 |
| Q2 2026 | 157 | 5 | 26.83M | $5B | 3 | 2 |
| Q1 2026 | 157 | 5 | 26M | $2.5B | 3 | 2 |
| Q4 2025 | 157 | 4 | 25.95M | $2.1B | 1 | 2 |
| Q3 2025 | 157 | 3 | 27.52M | $1.3B | 2 | 1 |
| Q2 2025 | 157 | 3 | 27.32M | $1B | 2 | 1 |
| Q1 2025 | 156 | 3 | 25.16M | $889.8M | 2 | 0 |
| Q4 2024 | 156 | 3 | 24.18M | $1.1B | 3 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Andrew Spokes | 13.42M | 13.55M | 13.6M | 14.58M | 14.63M | 14.33M | 13.53M | 13.25M |
| Louis Bacon | 85.18K | 81.7K | 55.6K | — | — | — | — | — |
| Julian and Felix Baker | · | 11.44M | 9.56M | 9.46M | 9.46M | 9.36M | 7.94M | 7.94M |
| Brandon Haley | · | 1.36M | 2.47M | 1.91M | 3.44M | 3.63M | 3.69M | 3M |
| Stanley Druckenmiller | · | 399.59K | 315.86K | — | — | — | — | — |
| Temasek | — | — | — | 3.15K | — | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own RVMD?
In their latest 13F filings: Andrew Spokes (14.4% of the portfolio, $2.8B), Julian and Felix Baker (10.7% of the portfolio, $2.1B), Stanley Druckenmiller (1.72% of the portfolio, $74.8M), Brandon Haley (0.58% of the portfolio, $254.6M), Louis Bacon (0.49% of the portfolio, $17.5M).
Who bought RVMD last quarter?
Julian and Felix Baker (added 20%), Stanley Druckenmiller (added 27%), Louis Bacon (added 4.3%). “Last quarter” is each investor's latest reported quarter.
Who sold RVMD last quarter?
Reduced: Andrew Spokes (1.0% fewer shares), Brandon Haley (45% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Revolution Medicines (RVMD)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/RVMD/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to RVMD by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.